InvestSMART

Company announcements

leave blank for all companies
leave blank for all announcements
announcements

~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Update - Notification of buy-back - NEU 29 Apr 2026 8:45AM $11.930 $12.470 risen by 4.53%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Virtual AGM online guide 24 Apr 2026 1:27PM $12.225 $12.470 risen by 2%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Notice of Annual General Meeting/Proxy Form 24 Apr 2026 1:22PM $12.225 $12.470 risen by 2%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Appendix 4G 24 Apr 2026 1:05PM $12.260 $12.470 risen by 1.71%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 2025 Annual Report to shareholders 24 Apr 2026 12:58PM $12.140 $12.470 risen by 2.72%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Update - Notification of buy-back - NEU 21 Apr 2026 8:56AM $12.480 $12.470 fallen by 0.08%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Update - Notification of buy-back - NEU 20 Apr 2026 8:32AM $12.490 $12.470 fallen by 0.16%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Update - Notification of buy-back - NEU 17 Apr 2026 8:48AM $12.480 $12.470 fallen by 0.08%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Notification of cessation of securities - NEU 10 Apr 2026 4:55PM $12.520 $12.470 fallen by 0.40%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 DAYBUE STIX now broadly available in US for Rett syndrome 8 Apr 2026 9:47AM $12.300 $12.470 risen by 1.38%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Notification of cessation of securities - NEU 26 Mar 2026 5:49PM $11.850 $12.470 risen by 5.23%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Update - Notification of buy-back - NEU 24 Mar 2026 8:40AM $11.490 $12.470 risen by 8.53%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Update - Notification of buy-back - NEU 13 Mar 2026 8:26AM $11.950 $12.470 risen by 4.35%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Update - Notification of buy-back - NEU 10 Mar 2026 8:40AM $11.680 $12.470 risen by 6.76%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Change of Director's Interest Notice - J Basile 6 Mar 2026 10:25AM $12.590 $12.470 fallen by 0.95%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Update - Notification of buy-back - NEU 4 Mar 2026 8:42AM $12.560 $12.470 fallen by 0.72%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Acadia confirms plan to request CHMP re-examination 3 Mar 2026 9:50AM $13.770 $12.470 fallen by 9.44%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Investor presentation, 27 February 2026 27 Feb 2026 11:54AM $13.480 $12.470 fallen by 7.49%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 2025 royalty income A$65m, profit after tax A$30m 27 Feb 2026 9:59AM $13.440 $12.470 fallen by 7.22%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Appendix 4E and 2025 full year accounts 27 Feb 2026 9:53AM $13.440 $12.470 fallen by 7.22%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Acadia reports DAYBUE net sales for 2025 and 2026 guidance 26 Feb 2026 11:15AM $12.710 $12.470 fallen by 1.89%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Pause in Trading 26 Feb 2026 9:53AM $12.710 $12.470 fallen by 1.89%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Update - Notification of buy-back - NEU 13 Feb 2026 9:32AM $13.570 $12.470 fallen by 8.11%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Notification of buy-back - NEU 11 Feb 2026 6:24PM $13.430 $12.470 fallen by 7.15%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,577 Notification of Neuren investor webinar on 12 February 2026 11 Feb 2026 5:05PM $13.430 $12.470 fallen by 7.15%

1 - 25 of 808 results

Page 1 of 33

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.